A molecular beacon biosensor for viral RNA detection based on HyCaSD strategy.
W Saisuk1, C Srisawat2, S Yoksan3
1Department of Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Analytica Chimica Acta
|August 7, 2022
Summary
A new molecular beacon biosensor enhances viral RNA detection sensitivity by 20-fold. This rapid, single-tube test brings accurate diagnostics closer to point-of-care applications for infectious diseases.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Biosensor Technology
Background:
- Viral RNA detection is crucial for diagnosing infectious diseases.
- Existing diagnostic methods may lack sensitivity or speed for point-of-care use.
- The HyCaSD platform offers a foundation for improved molecular detection.
Purpose of the Study:
- To develop a molecular beacon (MB) biosensor for efficient viral RNA detection.
- To enhance the sensitivity and speed of the HyCaSD platform.
- To advance the potential for point-of-care viral diagnostics.
Main Methods:
- Developed HyCaSD molecular beacon probes labeled with Cy5 and BHQ3.
- Utilized specific hybridization to target RNA sequences, causing hairpin probe unfolding.
- Detected fluorescence signal in real-time for RNA quantification.
Main Results:
- Achieved a limit of detection (LOD) of 100 copy equivalents per reaction.
- Demonstrated a 20-fold increase in sensitivity compared to the original HyCaSD platform.
- Implemented a single-step, single-tube, real-time RNA detection procedure.
Conclusions:
- The MB-based HyCaSD significantly improves viral RNA detection sensitivity and efficiency.
- The developed biosensor is a promising tool for rapid, point-of-care diagnostics of viral infectious diseases.
- This advancement facilitates quicker diagnosis and management of viral infections.
